Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in ItalyAnna Loraschi, Marco Cosentino, Francesco Patti et al.|Neurological Sciences|2016Cited by 20
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological SocietyG. Tedeschi, Angelo Ghezzi, L. M. E. Grimaldi et al.|Neurological Sciences|2011Cited by 19
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationDiana Ferraro, Carlo Pozzilli, Pietro Iaffaldano et al.|Journal of Neurology|2021Cited by 10
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders RegisterPaola Mosconi, Marinella Clerico, Tommaso Guerra et al.|Neurological Sciences|2023Cited by 9
Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders registerRoberto Bergamaschi, Maura Danni, Ettore Beghi et al.|Neurological Sciences|2022Cited by 4